Not all leaders are good leaders.Perhaps you’ve lost an important executive or you’re establishing a local leadership team. You know that the leader you choose will have a major impact on the organization. So how can you avoid hiring the…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Novartis Jettisons Key Evidence from Diovan Promotion
February 6, 2013
-
BUSINESS Nesp, Mircera Jostling for Market Shares of Pre-Dialysis CKD Patients
February 5, 2013
-
BUSINESS Aricept Fails to Meet Minimum Sales Target in Japan: Eisai
February 4, 2013
-
BUSINESS Marketing Ability Could Become Decisive Factor as All DPP-4 Inhibitors Are Likely to Obtain the Same Concurrent-use Indications
February 4, 2013
-
BUSINESS Daiichi Sankyo Sees 7.1% Sales Rise in April-December, Cuts Domestic Forecast for Nexium
February 1, 2013
-
REGULATORY CRO Association to Compile Guidelines for Third-Party Outsourcing after GCP Revision
February 1, 2013
-
ORGANIZATION Wholesale Industry FTC Prohibits Drink Donations at Academic Confabs, Keeps Pace with Drug Makers
January 31, 2013
-
REGULATORY 13 Generic Makers Slapped with Improvement Order due to South Korean Supplier’s GMP Violation
January 30, 2013
-
ORGANIZATION Wholesale Industry FTC Curbs Returns of Drugs to Be Discarded
January 29, 2013
-
BUSINESS Medipal Group Introduces Special Mini Cooler for New Orphan Drug
January 29, 2013
-
REGULATORY PAFSC First Committee on New Drugs to Discuss Approval of Japan’s First FD Treatment
January 28, 2013
-
BUSINESS Novartis, Sanofi Dissolve Partnership on Equa Copromotion
January 25, 2013
-
BUSINESS Transparency GL: Drug Makers Might Disclose Individual Payments Only Upon Request
January 24, 2013
-
BUSINESS Merck Serono Aims for Top 10 Slot in Oncology Field
January 23, 2013
-
BUSINESS Sanofi’s Dellegra Promotion to Home in on Stuffy Nose
January 22, 2013
-
BUSINESS Pfizer Detailing Infectious Disease Portfolios across Divisions
January 21, 2013
-
BUSINESS Drug Makers’ Specialty Care Pipelines Hit Snags in Late-Stage Development
January 21, 2013
-
ORGANIZATION JPMA Bolstering ICH Activities to Propose New Topics from Industry
January 18, 2013
-
BUSINESS Celgene K.K. Focused on MR Training Aiming for No. 1 Ranking Among Hematologists in 2013
January 18, 2013
-
BUSINESS OrphanPacific’s Orphan Drug Biz Faces Rough Going with Rising Costs
January 17, 2013
ページ
Earlier this month, Health Minister Keizo Takemi called on the top executives of 13 major generic makers to restructure the industry with a product consolidation target of “around five companies per API.” While a variety of restructuring options are conceivable,…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…